Global Vaccine Market Pipeline Analysis
US$ 1,500.00
... sub-divided into four groups namely, pediatrics, adolescents, adults and elderly. Though the vaccines segment forms a very small portion of the ... market is expected to surpass estimated USD 100 billion by 2025. “Global Vaccine Market Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...
January 2014
1150 pages
Designing Clinical Trials to Show Value
US$ 595.00
... is changing. In Designing Clinical Trials to Show Value, you will: Understand how new concepts of value created by cost-conscious healthcare stakeholders are transforming clinical development programmes ... Understand new trends in clinical trials that promise to deliver product value sought by regulators, health systems and patients Designing Clinical Trials to Show Value answers key questions ...
December 2013
63 pages
Personalizing Cancer Drugs Trends: Market Research Report
US$ 1,450.00
... pace of growth is not being reported in the area of development of drugs and therapies for treating cancers. The report also predicts that the ... analysis in the diagnosis and treatment of various types of cancer, clearing the path for personalized medicine towards becoming a common expression associated with ...
December 2013
28 pages
2014 U.S. Pharmaceutical Preparation Mfg. Industry-Capital & Expenses Report
US$ 149.00
The 2014 U.S. Pharmaceutical Preparation Mfg. Industry-Capital & Expenses Report, published annually by Barnes Reports, contains timely and accurage industry statistics, forecasts and demographics. The report features 2014 current and 2015 forecast estimates on the cost of materials, capital expenditures, ...
December 2013
87 pages
2014 U.S. Pharmacies & Drug Stores Industry-Capital & Expenses Report
US$ 149.00
The 2014 U.S. Pharmacies & Drug Stores Industry-Capital & Expenses Report, published annually by Barnes Reports, contains timely and accurage industry statistics, forecasts and demographics. The report features 2014 current and 2015 forecast estimates on the cost of materials, capital expenditures, ...
December 2013
231 pages
Global and China Insulin Industry Report, 2013-2017
US$ 1,900.00
... Lilly, of which, Novo Nordisk accounted for 60.3% in 2012. While in recombinant human insulin market segments, the local Chinese enterprise –Tonghua Dongbao Pharmaceutical ... also received clinical approval issued by SFDA in September 2013. Global and China Insulin Industry Report, 2013-2017 mainly covers the ...
December 2013
80 pages
2014 Opportunities in the UK Therapeutic Drug Monitoring (TDM) Market
US$ 1,960.00
... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...
December 2013
247 pages
2014 Opportunities in the US Therapeutic Drug Monitoring (TDM) Market
US$ 2,800.00
... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...
December 2013
249 pages
2014 Opportunities in the Spanish Drugs of Abuse Testing Market
US$ 1,960.00
... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...
December 2013
260 pages
2014 Opportunities in the UK Drugs of Abuse Testing Market
US$ 1,960.00
... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...
December 2013
260 pages
2014 Opportunities in the US Drugs of Abuse Testing Market
US$ 2,800.00
... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...
December 2013
262 pages
2014 Opportunities in the European Drugs of Abuse Testing Market
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
December 2013
300 pages
Research Report on China Antidiabetic Drug Market, 2014-2018
US$ 2,400.00
... and cure to diabetes become more difficult. The prevalence rate of diabetes in China increased from less 1% in 1980 to about 5.5% in 2022, 11% in 2013, which become the ... . The CAGR in 2009-2013 exceeded 17%. CRI estimates the CAGR of China antidiabetic drug market size will keep 15%. For global pharmaceutical ...
December 2013
60 pages
Market Access for Orphan Drugs: assessing the global landscape
US$ 595.00
... high cost of orphan drugs. International and regional regulations are also hurdles to be overcome, despite harmonisations efforts by agencies. In Market Access for Orphan Drugs: Assessing the Global Landscape, FirstWord goes around the world to lay bare the market access issues affecting orphan drug developers in the ...
November 2013
100 pages
Russian Pharmaceutical Market Outlook to 2017
US$ 800.00
... players will continue to boost the market. According to our report, “Russian Pharmaceutical Market Outlook to 2017”, the pharmaceutical market is anticipated to grow at a CAGR ... focuses on the emerging pharmaceutical clusters in Russia and the role they will play in shaping the market. The market has been ...
November 2013
80 pages
China Large Volume Parenteral (LVP) Industry Report, 2013-2015
US$ 1,800.00
... context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which ... balance injection, therapeutic injection, nutrition injection, injection for blood volume expansion and peritoneal dialysis fluid injection and other market ...
November 2013
65 pages
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023
US$ 3,000.00
... reach $143.7bn by 2023. GMR Data’s latest report 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ explains just how ... Within GMR Data’s 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key cancer drugs and treatments in the market currently and ...
November 2013
243 pages
2014 Nucleic Acid Testing Market: Strategic Assessments of Leading Strategic Suppliers
US$ 2,800.00
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as ... assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, ...
November 2013
549 pages
Physician Views: What opportunity for Novo Nordisk's Victoza in obesity?
US$ 695.00
... mixed opinions on the commercial opportunity, but one of the more intriguing near- ... the US within the next few months, this week's Physician Views poll targets general practitioners and internal ... obesity (and based on available Phase III data), in what percentage of obese patients would you consider prescribing ...
November 2013
Research Report on China Osteoporosis Drug Market, 2013-2017
US$ 1,800.00
... vitamin D and analogues, and calcitonins always took up above 98% shares of China osteoporosis drug market. The market share of bisphosphonates increased at the ... global pharmaceutical enterprises, they will find huge market opportunities in China. Through this report, the readers can acquire the following ...
November 2013
30 pages
2014 Analysis of the Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
318 pages
2014 Analysis of the UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs
US$ 1,960.00
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
260 pages
2014 Analysis of the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
300 pages
2014 Analysis of the Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ...
November 2013
313 pages
2014 Analysis of the European Therapeutic Drug Monitoring (TDM) Market : Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and ...
November 2013
291 pages
US Lung Cancer Drug Pipeline Analysis
US$ 1,800.00
... annual statistics published, an estimated 201,144 people in the United States were diagnosed with lung cancer. This figure included 107,164 men and ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Lung Cancer Drug Pipeline Analysis ...
November 2013
385 pages
US Colorectal Cancer Drug Pipeline Analysis
US$ 1,500.00
... that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Colorectal Cancer Drug Pipeline ...
November 2013
242 pages
US Parkinson's Disease Drug Pipeline Analysis
US$ 1,500.00
... in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Parkinson’s Disease Drug Pipeline Analysis ...
November 2013
241 pages
Pharmaceutical Companies Directory-Global-Excel Format
US$ 297.00
This is an excel file with over 5,000 global pharma industry contacts at 1,600 pharmaceutical companies around the globe. This Directory provides profiles of the international leaders in the pharma industry in Microsoft Excel format so the data can be searched, sorted and exported for other ...
October 2013
5000 pages
Pharmaceutical Industry in China Q3 2013 - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
US$ 3,400.00
“Pharmaceutical Industry China Q3 2013 – Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, ... position within the market Top Five Contract Pharmaceutical Export Markets of China Major players within China’s leading therapeutic markets (e.g., cancer, allergy, liver ...
October 2013
145 pages
Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013
US$ 3,400.00
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This report scrutinises ...
October 2013
161 pages
